Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 29, 2020

SELL
$33.87 - $55.93 $7,451 - $12,304
-220 Closed
0 $0
Q1 2020

Apr 22, 2020

BUY
$31.52 - $53.81 $6,934 - $11,838
220 New
220 $8,000
Q4 2018

Jan 29, 2019

SELL
$42.73 - $76.53 $360,299 - $645,300
-8,432 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$73.22 - $99.55 $617,391 - $839,405
8,432 New
8,432 $710,000

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $3.24B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Hanseatic Management Services Inc Portfolio

Follow Hanseatic Management Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hanseatic Management Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hanseatic Management Services Inc with notifications on news.